摘要目的 探讨新型胃癌筛查评分系统在医院就诊人群中的临床应用价值.方法 采用新型胃癌筛查评分系统对2017年4月至2018年8月间因各种消化道症状在温州市中心医院就诊且符合该筛查流程的患者资料进行回顾性分析,根据新型胃癌筛查评分系统的评分结果将所有患者分为3组,即低危组(0～11分)、中危组(12～16分)及高危组(17～ 23分),对3组患者的胃癌及癌前状态的检出情况进行对比分析.结果 共2 674例患者纳入研究,低危组1 694例(63.35％),中危组833例(31.15％),高危组147例(5.50％).共检出胃癌73例,胃癌检出率为2.73％(73/2 674);3组患者的胃癌检出率分别为1.06％(18/1 694)、4.32％ (36/833)及12.93％(19/147),3组患者间胃癌的检出率两两比较,差异有统计学意义(P均＜0.05).早期胃癌的检出率中危组[2.04％(17/833)]、高危组[4.08％(6/147)]明显高于低危组[0.35％(6/1 694),P均＜0.05].结论 采用新型胃癌筛查评分系统,不仅可以显著提高医院就诊人群的胃癌检出率,而且同时能提高早期胃癌诊断率.

abstractsObjective To explore the clinical value of a new scoring system for gastric cancer screening in hospital visits.Methods A new scoring system for gastric cancer screening was used to retrospectively analyze data of patients who visited Wenzhou Central Hospital for various digestive symptoms from April 2017 to August 2018 and met the screening requirements.All patients were divided into three groups according to the grading results of the new scoring system:low-risk group (0-11 points),medium-risk group (12-16 points) and high-risk group (17-23 points).A comparative analysis was performed on the detection of gastric cancer and gastric precancerous conditions among the three groups.Results A total of 2 674 patients were included in this study,1 694(63.35％) in the low-risk group,833(31.15％) in the medium-risk group,and 147(5.50％) in the high-risk group.The total detection rate of gastric cancer was 2.73％ (73/2 674).The detection rates were 1.06％ (18/1 694),4.32％ (36/833) and 12.93％ (19/147) in the three groups,respectively.There were significant differences in the detection rate of gastric cancer between any two of the three groups (all P ＜ 0.05).The detection rates of early gastric cancer in medium-risk group [2.04％ (17/833)] and high-risk group [4.08 ％ (6/147)] were significantly higher than that in the low-risk group[0.35％(6/1 694),all P＜0.05].Conclusion The new gastric cancer screening scoring system can not only significantly improve the detection rate of gastric cancer in hospital visits,but also improve the diagnostic rate of early gastric cancer.